Illumina

Director, General Manager - Latin America

Sao Paulo, Sao Paulo, Brazil

Auto‑apply with AI Apply

$150,000 – $250,000Compensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Life Sciences, Biotechnology, HealthcareIndustries

Requirements

The ideal candidate should possess a Bachelor's degree and have a minimum of 10 years of experience in a leadership role, preferably within the life sciences or biotechnology industry. Strong strategic leadership skills, a deep understanding of Latin American markets, and proven experience driving revenue growth are essential. Experience with P&L responsibility and managing large, complex organizations are also required.

Responsibilities

As the Director, General Manager - Latin America, you will be responsible for setting the strategic direction of the sub-region, aligning Illumina functions, and ensuring the success of the business within the geography. You will lead a team of district sales managers and sales specialists, drive accelerated revenue growth, and oversee the development of go-to-market strategies. Additionally, you will be accountable for achieving financial and strategic goals, fostering customer satisfaction, and managing the genomics ecosystem within the region.

Skills

Strategic Leadership

P&L Management

Revenue Growth

Latin American Markets

Sales Management

Go-to-Market Strategy

Financial Management

Ecosystem Management

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters

1998Year Founded

$27.2MTotal Funding

IPOCompany Stage

Venture Capital, BiotechnologyIndustries

5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.

Standardizing proteomics data across platforms could challenge Illumina's data reliability.

Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.

The company offers innovative array-based solutions for DNA, RNA, and protein analysis.

Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.

Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.

Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI

Try Jobo Free